3M Company Common Stock (MMM)
Healthcare › Surgical & Medical Instruments & Apparatus
Price History
Feb 9, 2026 — Jul 6, 2026Investment Snapshot
- Trading 461% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 5/9 — moderate financial health
- Strong ROE of 101.9% with 13.4% net margin
3M Company Common Stock (MMM) is a Healthcare company operating in Surgical & Medical Instruments & Apparatus, listed on the NYSE , with a market capitalisation of $87.6 billion . Key value metrics: P/E ratio 26.3, P/B ratio 26.85, Piotroski F-Score 5 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
3M Company Common Stock — Fundamental Analysis Summary
3M Company Common Stock (MMM) is currently trading 461% above its Graham Number of $29.96, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 26.3x.
On financial health, MMM shows a moderate Piotroski F-Score of 5/9, and strong return on equity of 101.9% (sector average: -20.6%), and high leverage with a debt-to-equity ratio of 3.85.
StockPik's composite Value Score for MMM is 52/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
MMM reports a solid gross margin of 41.7% (sector average: 39.4%) and a strong operating margin of 21.1%.
MMM shows revenue growing at 2% year-over-year, with earnings declining at 22%.
MMM pays a modest dividend yield of 1.8%.